Stock Events

Stock Events

NeuroSense Therapeutics (NRSNW) Q2 2025 Earnings

28MayConfirmed

Q3 2024

Q4 2024

Q2 2025

Q2 2025

-0.19

-0.14

-0.09

-0.04

Details

Expected EPS

-0.10425

Actual EPS

-0.10425

Surprise EPS

0

Surprise Percent

+0%

Description

NeuroSense Therapeutics (NRSNW) has reported earnings of -0.10425 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.